Literature DB >> 7568911

Molecular aspects of tetanus and botulinum neurotoxin poisoning.

G Ahnert-Hilger1, H Bigalke.   

Abstract

Clostridial neurotoxins, tetanus and the botulinum toxins A-G, are high molecular weight proteins consisting of a heavy chain which is responsible for the internalisation and a light chain possessing a zinc-dependent proteolytic activity. They exclusively proteolyse either the vesicle membrane protein, synaptobrevin or two integral plasma membrane proteins, SNAP 25 and syntaxin. Together with cytosolic proteins these proteins form the SNARE complex involved in vesicle exocytosis, and their cleavage blocks the latter process. Clostridial neurotoxins have now become powerful tools to investigate the final events occurring during secretion in neuronal, endocrine, and non-neuronal cells. They are applied to dissect the specific interactions of the SNARE protein complex with cytosolic fusogens and other modulators of exocytosis. Whereas exocytosis is not essential for the survival of cells, the organism as a whole will fall victim to a few nanograms since interneuronal and neuromuscular transmission is vital to muscular control, especially in respiration. Although all clostridial neurotoxins by their light chains attack proteins of the SNARE complex, tetanus toxin and the various botulinum toxins differ dramatically in their clinical symptoms. The biological information for this difference resides on the respective heavy chains which select different transport routes carrying the light chain from the place of entrance to the final compartment of action. So far the different transport vesicles used either by the various botulinum neurotoxins or by tetanus toxin are not yet defined. Nevertheless at least one of the botulinum toxins serves as a beneficial drug in the treatment of severe neuromuscular spasms.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7568911     DOI: 10.1016/0301-0082(95)00003-e

Source DB:  PubMed          Journal:  Prog Neurobiol        ISSN: 0301-0082            Impact factor:   11.685


  16 in total

1.  Expression of Kv1 potassium channels in mouse hippocampal primary cultures: development and activity-dependent regulation.

Authors:  G Grosse; A Draguhn; L Höhne; R Tapp; R W Veh; G Ahnert-Hilger
Journal:  J Neurosci       Date:  2000-03-01       Impact factor: 6.167

2.  SNARE protein-dependent glutamate release from astrocytes.

Authors:  A Araque; N Li; R T Doyle; P G Haydon
Journal:  J Neurosci       Date:  2000-01-15       Impact factor: 6.167

3.  A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of tension-type headache.

Authors:  M Porta
Journal:  Curr Rev Pain       Date:  2000

4.  Modulation of an early step in the secretory machinery in hippocampal nerve terminals.

Authors:  L E Trudeau; Y Fang; P G Haydon
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

5.  Regulation of kinetic and pharmacological properties of synaptic NMDA receptors depends on presynaptic exocytosis in rat hippocampal neurones.

Authors:  R Lindlbauer; R Mohrmann; H Hatt; K Gottmann
Journal:  J Physiol       Date:  1998-04-15       Impact factor: 5.182

6.  Distinct roles of synaptic and extrasynaptic NMDA receptors in excitotoxicity.

Authors:  R Sattler; Z Xiong; W Y Lu; J F MacDonald; M Tymianski
Journal:  J Neurosci       Date:  2000-01-01       Impact factor: 6.167

7.  Synaptic secretion of BDNF after high-frequency stimulation of glutamatergic synapses.

Authors:  M Hartmann; R Heumann; V Lessmann
Journal:  EMBO J       Date:  2001-11-01       Impact factor: 11.598

8.  Exocytosis of ATP from astrocyte progenitors modulates spontaneous Ca2+ oscillations and cell migration.

Authors:  Katharine Striedinger; Paolo Meda; Eliana Scemes
Journal:  Glia       Date:  2007-04-15       Impact factor: 7.452

9.  Complex gangliosides at the neuromuscular junction are membrane receptors for autoantibodies and botulinum neurotoxin but redundant for normal synaptic function.

Authors:  Roland W M Bullens; Graham M O'Hanlon; Eric Wagner; Peter C Molenaar; Keiko Furukawa; Koichi Furukawa; Jaap J Plomp; Hugh J Willison
Journal:  J Neurosci       Date:  2002-08-15       Impact factor: 6.167

Review 10.  [Treatment of sialorrhea with botulinum toxin: an overview].

Authors:  J Hagenah; K G Kahl; S Steinlechner; R Lencer; C Klein
Journal:  Nervenarzt       Date:  2005-04       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.